tiprankstipranks

Omega Therapeutics initiated with an Outperform at Raymond James

Raymond James initiated coverage of Omega Therapeutics with an Outperform rating and $12 price target.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue